Company Profile

Boulder Care Inc
Profile last edited on: 10/10/22      CAGE: 89L68      UEI: T231F5K6Z6L3

Business Identifier: Digital treatment program supporting long-term recovery for opioid use
Year Founded
2017
First Award
2019
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

223 Bedford Avenue Unit 1167
Brooklyn, NY 11211
   (704) 604-8343
   N/A
   www.boulder.care
Location: Multiple
Congr. District: 12
County: Kings

Public Profile

With personnel and facilities in several states, Boulder is structured as a digital health platform expanding access to effective treatment for opiate use. Offering telehealth treatment for opioid addiction, the effort is to move the behavioral health industry forward by offering better experiences for patients and their care teams. Anchored in years of clinical expertise, proven research, and learnings from participants, Boulder Care provides those needing long-term support and medical treatment for their addiction. The firm's telehealth-based program - designed by addiction medicine specialists and people with lived experience of recovery - is structured to improve the lives of having opioid use disorder with required medication, resources, and support.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Stephanie Papes -- Founder and CEO

  Jordon D Bosse -- former

  Trip Cothren -- VP, Business Development

  Mj Darby -- Founder and Chief Development Officer

  David Lerman -- Chief Technology Officer & Co-Founder

  Amanda Wilson -- Founder

Company News

There are no news available.